Search Results - "Postorino, Elisa Imelde"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Use of allogeneic platelet-rich plasma for the treatment of autoimmune ocular surface disorders: case series by Mancini, Maura, Postorino, Elisa Imelde, Gargiulo, Ludovica, Aragona, Pasquale

    Published in Frontiers in ophthalmology (2023)
    “…To assess the effectiveness of topical allogeneic platelet-rich plasma (PRP) eye drops for the treatment of symptoms and clinical signs in patients with severe…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Post-surgical management of cataract: Light and dark in the 2020s by Aragona, Pasquale, Postorino, Elisa Imelde, Aragona, Emanuela

    Published in European journal of ophthalmology (01-03-2021)
    “…Cataract surgery is the most frequently performed elective surgery worldwide. Although considered a safe procedure, potentially sight-threatening adverse…”
    Get full text
    Journal Article
  5. 5

    Ophthalmologic Manifestations of Primary Sjögren's Syndrome by Roszkowska, Anna Maria, Oliverio, Giovanni William, Aragona, Emanuela, Inferrera, Leandro, Severo, Alice Antonella, Alessandrello, Federica, Spinella, Rosaria, Postorino, Elisa Imelde, Aragona, Pasquale

    Published in Genes (04-03-2021)
    “…Sjögren's syndrome (SS) is a chronic, progressive, inflammatory, autoimmune disease, characterized by the lymphocyte infiltration of exocrine glands,…”
    Get full text
    Journal Article
  6. 6

    Early Corneal Innervation and Trigeminal Alterations in Parkinson Disease: A Pilot Study by Arrigo, Alessandro, Rania, Laura, Calamuneri, Alessandro, Postorino, Elisa Imelde, Mormina, Enricomaria, Gaeta, Michele, Marino, Silvia, Di Lorenzo, Giuseppe, Quartarone, Angelo, Anastasi, Giuseppe, Puzzolo, Domenico, Aragona, Pasquale

    Published in Cornea (01-04-2018)
    “…PURPOSE:To describe corneal innervation and trigeminal alterations in drug-naive patients with Parkinson disease (PD). METHODS:A case series study was…”
    Get full text
    Journal Article
  7. 7

    Changes in conjunctival epithelial cells after treatment with 0.2% xanthan gum eye drops in mild-moderate dry eye by Postorino, Elisa Imelde, Aragona, Pasquale, Rania, Laura, Spinella, Rosaria, Puzzolo, Domenico, Micali, Antonio, Mazza, Anna Maria Livia, Papa, Vincenzo

    Published in European journal of ophthalmology (01-05-2020)
    “…Purpose: To study the effects of xanthan gum eye drops on the ocular surface and conjunctival cytology of patients with mild-moderate dry eye. Methods: This…”
    Get full text
    Journal Article
  8. 8

    Clinical Efficacy, Tolerability and Safety of a New Multiple-Action Eyedrop in Subjects with Moderate to Severe Dry Eye by Roszkowska, Anna Maria, Inferrera, Leandro, Spinella, Rosaria, Postorino, Elisa Imelde, Gargano, Romana, Oliverio, Giovanni Wiliam, Aragona, Pasquale

    Published in Journal of clinical medicine (26-11-2022)
    “…Background: To assess the clinical efficacy, tolerability and safety of a new-generation ophthalmic solution containing cross-linked hyaluronic acid 0.15%…”
    Get full text
    Journal Article
  9. 9

    Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies by Aragona, Pasquale, Allegra, Alessandro, Postorino, Elisa Imelde, Rania, Laura, Innao, Vanessa, Wylegala, Edward, Nowinska, Anna, Ieni, Antonio, Pisani, Antonina, Musolino, Caterina, Puzzolo, Domenico, Micali, Antonio

    “…To investigate corneal confocal microscopic changes in nonneoplastic and neoplastic monoclonal gammopathies. Three groups of subjects were considered: group 1,…”
    Get full text
    Journal Article
  10. 10

    High-Tech Parameters for the Evaluation of Signs and Symptoms of Dry Eye Disease: Identification of Clinical Cut-Offs and Agreement with Low-Tech Tests by Fogagnolo, Paolo, Aragona, Pasquale, Strianese, Alfonso, Villani, Edoardo, Giannaccare, Giuseppe, Orfeo, Vincenzo, Mirisola, Valentina, Mencucci, Rita

    Published in Ophthalmology and therapy (01-11-2024)
    “…Introduction High-tech devices for the assessment of dry eye disease (DED) are increasingly available. However, the agreement between high- and low-tech…”
    Get full text
    Journal Article
  11. 11

    Effectiveness of a New Active Tear Substitute Containing 0.2% Hyaluronic Acid and 0.001% Hydrocortisone on Signs and Symptoms of Dry Eye Disease by Means of Low- and High-Tech Assessments by Fogagnolo, Paolo, Giannaccare, Giuseppe, Mencucci, Rita, Villani, Edoardo, Orfeo, Vincenzo, Aragona, Pasquale

    Published in Ophthalmology and therapy (01-01-2024)
    “…Introduction An innovative eye drops formulation containing 0.2% hyaluronic acid and a low concentration of hydrocortisone (0.001%; hereafter HALH) has been…”
    Get full text
    Journal Article